Literature DB >> 22634452

Cholera vaccine: new preventive tool for endemic countries.

Ramesh Verma1, Pardeep Khanna, Suraj Chawla.   

Abstract

Cholera is a major global public health problem and remains an important threat in almost every developing country, especially in areas where population overcrowding and poor sanitation are common, such as slums and refugee camps. Cholera is one of the most dreaded diseases in the world, in some cases leading to death within 24 h if left untreated. Without treatment, severe infection has a mortality rate of 30-50%. In 2007, WHO recorded 177,963 cholera cases and 4,031 deaths worldwide. However, the estimated actual burden of cholera is in the vicinity of 3 to 5 million cases and 100,000 to 130,000 deaths per year. The disease is endemic to parts of Africa, Asia, the Middle East and South America. Large outbreaks are common after natural disasters or in populations displaced by war, where there is inadequate sewage disposal and contaminated water. In India, during the 10-y period (1997-2006) studied, the states having the highest number of reported outbreaks were West Bengal, Orissa, Maharashtra and Kerala, which together accounted for 60% of all reported outbreaks. A review of cholera cases in India reported to WHO from 2003-2007 showed that the numbers were in the few thousands with a case fatality rate of < 1%. However, it is believed that the number of cholera cases and deaths occurring annually in India is much greater than the number reported. A literature review covering a four-year period from 2003 to 2006 found reported cholera outbreaks in 18 of the 35 States and Union Territories of India. Of these, 11 had cholera outbreaks reported for multiple years. Vietnam has produced a cheaper variant of killed whole-cell vaccine devoid of the B subunit. This vaccine contains both Vibrio cholerae O1 and O139, and provides 50 per cent protection for at least three years after vaccination. For endemic cholera, population-level immunity is relatively high, making control possible with relatively low vaccine coverage levels. This vaccine should be used in areas where cholera is endemic, particularly in those at risk of outbreaks, in conjunction with other prevention and control strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634452     DOI: 10.4161/hv.19083

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  9 in total

Review 1.  Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations.

Authors:  Eugene Lam; Amanda McCarthy; Muireann Brennan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Adult immunization in India: Importance and recommendations.

Authors:  Ramesh Verma; Pardeep Khanna; Suraj Chawla
Journal:  Hum Vaccin Immunother       Date:  2014-06-18       Impact factor: 3.452

3.  Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India.

Authors:  Shantanu K Kar; Alfred Pach; Binod Sah; Anna S Kerketta; Bikash Patnaik; VijayaLaxmi Mogasale; Yang Hee Kim; Shyam Bandhu Rath; Sunheang Shin; Hemant K Khuntia; Anuj Bhattachan; Mahesh K Puri; Thomas F Wierzba; Linda M Kaljee
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence.

Authors:  Shawn I Walsh; Arryn Craney; Floyd E Romesberg
Journal:  Bioorg Med Chem       Date:  2016-09-21       Impact factor: 3.641

Review 5.  Crossing borders: one world, global health.

Authors:  Christina R Phares; Luis Ortega
Journal:  Clin Infect Dis       Date:  2014-01       Impact factor: 9.079

6.  Isolation of Vibrio cholera El Tor Inaba From Lemna minor and Eichhornia crassipens Roots in Veracruz, Mexico.

Authors:  Edgar Cordoba Aguilar; Marisol Herrera Rivero; Alberto Rubi; Omar Arroyo-Helguera; Rocio Coutino Rodriguez
Journal:  Jundishapur J Microbiol       Date:  2014-03-01       Impact factor: 0.747

7.  Identification of burden hotspots and risk factors for cholera in India: An observational study.

Authors:  Mohammad Ali; Sanjukta Sen Gupta; Nisha Arora; Pradeep Khasnobis; Srinivas Venkatesh; Dipika Sur; Gopinath B Nair; David A Sack; Nirmal K Ganguly
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

Review 8.  Re-Emerging Vaccine-Preventable Diseases in War-Affected Peoples of the Eastern Mediterranean Region-An Update.

Authors:  Rasha Raslan; Skye El Sayegh; Sana Chams; Nour Chams; Angelo Leone; Inaya Hajj Hussein
Journal:  Front Public Health       Date:  2017-10-25

9.  Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.

Authors:  Cynthia Semá Baltazar; Florentina Rafael; José Paulo M Langa; Sergio Chicumbe; Philippe Cavailler; Bradford D Gessner; Lorenzo Pezzoli; Américo Barata; Dores Zaina; Dortéia L Inguane; Martin A Mengel; Aline Munier
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.